• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

As biosimilars loom, Roche's Genentech plans to lay off 223 staffers in California

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 15, 2018 at 10:42: PM
via As Roche braces for the biosimilar assault on blockbuster cancer drugs, its Genentech unit is parting ways with 223 staffers in California. In a WARN notice posted on the state’s website, Genentech disclosed that it expects to lay off the employees starting at the end of the month.

article source
 

<



Similar threads

cafead
AbbVie’s Humira continues to lose market share as biosimilars gain ground
Replies
0
Views
43
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
AbbVie&#039;s tight grip on Humira market raises concerns about biosimilars
Replies
0
Views
45
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA approves two biosimilars to blockbuster eye drug Eylea
Replies
0
Views
94
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Biosimilars are gaining ground. The IRA could push them even further next year.
Replies
0
Views
50
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Replies
0
Views
84
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote